We sought out to shed light on the buzzy beauty devices, which have been linked to everyone from Sabrina Carpenter to Cynthia ...

Iridex (IRIX) announced a recently published independent, retrospective study in Ophthalmology and Therapy. The study demonstrates that ...

The study, conducted at the University Eye Clinic Maastricht, aimed to assess the effectiveness, repeatability, and safety of retreatment in real-world clinical practice using MicroPulse TLT. The ...

"SLT is a widely used first-line laser therapy for glaucoma but relies on a Q-switched Nd:YAG laser, which induces cellular ...

Eye doctors are in a big fight at the New Hampshire State House over who can perform certain laser procedures to treat ...

The study evaluated thermal dynamics associated with CW-TSCPC and TLT using MicroPulse technology, such as temperature peak, ...

Iridex (IRIX) announced a newly published study in Translational Vision Science & Technology, TVST, examining the thermal dynamics of transscleral ...

Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal ...

Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment ...

ViaLase announced the first patient has been treated in its US-based Investigational Device Exemption (IDE) clinical trial ...

Stead added that while SLT is now the first treatment that is offered to patients, a range of topical medications in the form ...

ViaLase, Inc., a clinical-stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced that the first patient has been treated in its U.S.